Despite advances in our understanding of the pathophysiology of many cardiovascular
diseases (CVDs) and expansion of available therapies, the global burden of CVD …

Purpose Hematology–oncology patients undergoing chemotherapy and hematopoietic stem
cell transplantation (HSCT) recipients are at risk for oral complications which may cause …

The aim of this prospective, two center study was to investigate the dynamics of the microbial
changes in relation to the development of ulcerative oral mucositis in autologous SCT …

Dental treatment of patients with leukemia should be planned on the basis of antineoplastic
therapy which can be chemotherapy with or without radiotherapy and bone marrow …

Bacterial bloodstream infections (BSI) cause significant transplant-related morbidity and
mortality following allogeneic hematopoietic cell transplantation (allo-HCT). This manuscript …

Hematopoietic stem cell transplantation (HSCT) is widely used as a potentially curative
treatment for patients with various hematological malignancies, bone marrow failure …

Despite advances in transplant medicine, prevalence of complications after hematopoietic
stem cell transplantation (HSCT) remains high. The impact of pre-HSCT oral health factors …

Abstract Characterization of the role of oral microbiome in cancer therapy-induced oral
mucositis (CTOM) is critical in preventing the clinically deleterious effects on patients' health …

Treatment‐related toxicities are common among patients with head and neck cancer,
leading to poor clinical outcomes, reduced quality of life, and increased use of healthcare …

Oral mucositis (OM) is a frequent complication of stem cell transplantation-associated toxicity
in haematological malignancies, contributing to mortality. Therapy still remains mainly …